Kurzrock, Razelle

Molecular determinants of drug-specific sensitivity for epidermal growth factor receptor (EGFR) exon 19 and 20 mutants in non-small cell lung cancer

Tsigelny, I. F., Wheler, J. J., Greenberg, J. P., Kouznetsova, V. L., Stewart, D. J., Bazhenova, L., & Kurzrock, R. (2015) · Oncotarget

Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research

Cited by 30

Phase I trial of MEK 1/2 inhibitor pimasertib combined with mTOR inhibitor temsirolimus in patients with advanced solid tumors

Mita, M., Fu, S., Piha-Paul, S. A., Janku, F., Mita, A., Natale, R., Guo, W., Zhao, C., Kurzrock, R., & Naing, A. (2017) · Investigational New Drugs

Melanoma and MAPK PathwaysPI3K/AKT/mTOR signaling in cancer

Cited by 26

Prognostic utility of pre- and postoperative circulating tumor DNA liquid biopsies in patients with peritoneal metastases

Baumgartner, J. M., Riviere, P., Lanman, R. B., Kelly, K. J., Veerapong, J., Lowy, A. M., & Kurzrock, R. (2020) · Annals of Surgical Oncology

Cancer Genomics and DiagnosticsIntraperitoneal and Appendiceal Malignancies

Cited by 25

Machine learning model to predict oncologic outcomes for drugs in randomized clinical trials

Schperberg, A. V., Boichard, A., Tsigelny, I. F., Richard, S. B., & Kurzrock, R. (2020) · International Journal of Cancer

Computational Drug Discovery MethodsBreast Cancer Treatment Studies

Cited by 24

The National Clinical Trials Network: Conducting Successful Clinical Trials of New Therapies for Rare Cancers

Schott, A. F., Welch, J. J., Verschraegen, C. F., & Kurzrock, R. (2015) · Seminars in Oncology

Statistical Methods in Clinical TrialsCancer Genomics and Diagnostics

Cited by 20

Revisiting Clinical Trials Using EGFR Inhibitor-Based Regimens in Patients with Advanced Non-Small Cell Lung Cancer: A Retrospective Analysis of an MD Anderson Cancer Center Phase I Population

Wheler, J., Falchook, G., Tsimberidou, A. M., Hong, D., Naing, A., Piha-Paul, S., Chen, S. S., Heymach, J., Fu, S., Stephen, B., et al. (2013) · Oncotarget

Lung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment

Cited by 17

A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology

Lazar, V., Zhang, B., Magidi, S., Le Tourneau, C., Raymond, E., Ducreux, M., Bresson, C., Raynaud, J., Wunder, F., Onn, A., et al. (2023) · Therapeutic Advances in Medical Oncology

Cancer Immunotherapy and BiomarkersBreast Cancer Treatment Studies

Cited by 14